Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
Middleton, Gary, Prof, Palmer, Daniel H, Prof, Greenhalf, William, PhD, Ghaneh, Paula, Prof, Jackson, Richard, PhD, Cox, Trevor, PhD, Evans, Anthony, PhD, Shaw, Victoria E, PhD, Wadsley, Jonathan, MA, Valle, Juan W, Prof, Propper, David, MD, Wasan, Harpreet, MD, Falk, Stephen, MD, Cunningham, David, Prof, Coxon, Fareeda, MBBS, Ross, Paul, PhD, Madhusudan, Srinivasan, Prof, Wadd, Nick, MBBS, Corrie, Pippa, FRCP, Hickish, Tamas, MD, Costello, Eithne, PhD, Campbell, Fiona, MD, Rawcliffe, Charlotte, MSc, Neoptolemos, John P, Prof
Published in The lancet oncology (01.04.2017)
Published in The lancet oncology (01.04.2017)
Get full text
Journal Article